Propionate has been shown to: lower the fatty acid content in the liver and in plasma, reduce the amount of food eaten at meals, demonstrate immunosuppressive activity and help tissue sensitivity to insulin, all of which can be of benefit in the treatment and prevention of obesity and type-2 diabetes [173]. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.